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The SUMO Pathway Promotes Basic Helix-Loop-Helix Proneural
Factor Activity via a Direct Effect on the Zn Finger Protein Senseless
Lynn M. Powell,a Angela Chen,b Yan Chang Huang,b Pin Yao Wang,b Sadie E. Kemp,a* and Andrew P. Jarmana
Centre for Integrative Physiology, School of Biomedical Sciences, University of Edinburgh, Edinburgh, United Kingdom,a and Institute of Biomedical Sciences, National
Sun Yat-Sen University, Kaohsiung, Taiwanb
During development, proneural transcription factors of the basic helix-loop-helix (bHLH) family are required to commit cells to
a neural fate. InDrosophila neurogenesis, a key mechanism promoting sense organ precursor (SOP) fate is the synergy between
proneural factors and their coactivator Senseless in transcriptional activation of target genes. Here we present evidence that
posttranslational modification by SUMO enhances this synergy via an effect on Senseless protein. We show that Senseless is a
direct target for SUMOmodification and that mutagenesis of a predicted SUMOylationmotif in Senseless reduces Senseless/
proneural synergy both in vivo and in cell culture. We propose that SUMOylation of Senseless via lysine 509 promotes its syn-
ergy with proneural proteins during transcriptional activation and hence regulates an important step in neurogenesis leading to
the formation andmaturation of the SOPs.
Cell fate decisions in neurogenesis require proneural proteins,which are basic helix-loop-helix (bHLH) transcription factors
(7). In Drosophila, proneural proteins including Achaete (AC),
Scute (SC), Atonal (ATO), andAmos (AMOS) are essential for the
specification of sense organ precursors (SOPs) for the various
sense organs of the peripheral nervous system. The proneural pro-
teins are first expressed at low levels in groups of uncommitted
ectodermal cells known as the proneural clusters. This initial ex-
pression is under the control of upstreamprepattern transcription
factors, such as Pannier and Iroquois (42, 50). Subsequently, in
some cells (the presumptive SOPs) proneural proteins promote
upregulation of their own expression via autoregulatory enhanc-
ers. The proneural proteins bind to E-boxes within these enhanc-
ers as heterodimers with the ubiquitously expressed bHLH pro-
tein Daughterless (DA). The transition to autoregulation appears
to be critical for neural commitment and downstream gene acti-
vation (15, 69). How this transition is controlled is therefore an
important question.One of the factors regulating the specification
process is lateral inhibition via the Notch signaling pathway (4,
33). This counteracts proneural gene upregulation via the auto-
regulatory enhancers in non-SOP cells through the inhibitory En-
hancer of split [E(SPL)] bHLH proteins.
Another factor affecting proneural activity is the Zn finger
transcription factor, Senseless (SENS). SENS belongs to the GPS
(Gfi1/Pag-3/Senseless) family of proteins (30). This factor is cru-
cial for the production of mature SOPs (47, 53). In sensmutants,
SOPs begin to form but fail to complete specification, instead
undergoing apoptosis (47). SENS’s role in promoting neurogen-
esis appears to be closely involved withmodulating proneural fac-
tor activity. Without SENS the SOPS fail to maintain proneural
protein levels required for formation and survival (47, 53). sens is
a direct proneural target gene (29), and subsequently SENS pro-
tein is coexpressed with proneural proteins in SOPs (29, 70). In
this context SENS enhances proneural factor activity as a tran-
scriptional coactivator: it can form complexes with AC/DA and
SC/DA that greatly enhance their ability to stimulate gene expres-
sion via E-box binding sites (3, 29, 49). Although originally shown
for AC and SC (3), the same coactivation synergy can also be
observed for ATO/DA/SENS and AMOS/DA/SENS (49) and so
appears to be a general mechanism of proneural factor modula-
tion. Proneural/SENS synergy is thought to have an important
role in bypassing the negative regulatory effects of Notch signaling
in the SOP.
In addition to this coactivator activity, SENS can act as a direct
transcriptional repressor. This is mediated by SENS binding di-
rectly to an S-box motif (29, 43). In this manner, SENS represses
the rhomboid (rho) gene in embryonic abdominal segments (65).
Interestingly, repression via an S box has also been shown for the
ac autoregulatory enhancer (29). Thus, SENS can both repress and
promote ac transcription: binding to the S box directly inhibits
proneural autoregulation, whereas binding to proneural factors
promotes autoregulation via the E box (15, 29). This contradic-
tory function led to the proposal that SENS acts as a binary switch
to promote either proneural protein activation or proneural gene
repression under different circumstances (Fig. 1A and B) (29). In
this model, manipulation of SENS activity could have a profound
effect on proneural function and SOP formation, but it is unclear
how the switch between activating and repressing modes of SENS
action might be regulated. The initial suggestion was that it de-
pends on the level of SENS expression, such that low levels are
repressive (in ectodermal cells that will not become SOPs) while
coactivation is triggered only at higher expression levels (in SOPs)
(29). In this paper we address the possibility that posttranslational
modification might influence SENS’s function. Specifically, we
present evidence that modification by small ubiquitin-related
modifier (SUMO) protein promotes SENS’s coactivator activity.
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SUMO proteins are ubiquitin-like proteins that can become
conjugated to lysine residues in target proteins (27, 28). SUMO
and ubiquitin have similar structures, and their conjugation
mechanisms are remarkably similar. However, the function of
SUMOylation is quite distinct from that of ubiquitination. SUMO
targets are mostly high-molecular-weight nuclear proteins, and
SUMOylation alters their cellular function in a variety of ways,
including prevention of degradation by way of competing for
ubiquitination sites (26), alteration of subcellular localization (9),
modulation of protein stability (6), andmodification of transcrip-
tion factor activity (19, 21, 62). SUMOmodification consequently
has an important role in a large variety of biological processes.
Here we present data from in vivo and tissue culture experi-
ments consistent with a role for SUMOylation in promoting the
proneural/SENS synergy in Drosophila. In an S2 cell luciferase
assay, transcriptional activation synergy between SENS and the
proneural proteins SC and ATO was increased by enhancing
SUMOylation and decreased by deSUMOylation. Consistent with
a direct role for SUMO, SENS is SUMO-modified inDrosophila S2
cells and in an in vitro SUMOylation assay, and SENS with a mu-
tated SUMOylation motif was refractory to SUMO stimulation.
An in vivomisexpression assay revealed genetic interactions between
SUMO and SENS, as well as with the proneural proteins themselves,
that were dependent on the presence of a SUMOylation motif. We
propose that SUMOylation of SENS via lysine 509 (K509) promotes
its synergistic interactionwith proneural proteins, thereby regulating
their activity, and hence regulating an important step in neurogen-
esis.
MATERIALS AND METHODS
Fly stocks. Fly stocks used as previously described are 109(2)68gal4/CyO
(31), UAS-ato (32), UAS-sc (13), and UAS-sens (47). UAS-FLAG-sumo/CyO
flies were a kind gift from Minghua Nie and Albert Courey. UAS-sens-attB
lines for wild-type andmutated SENS were made as described below.
Plasmid constructs. Protein expression constructs RactHAdh, RactH-
Adh-da, and pAc-scwere donated by Christos Delidakis (20). pAc-sens for
SENS expression in the S2 cell cotransfection assay was a kind gift from
Hamed Jafar-Nejad (29). pAc-FLAG-sens for expression of SENS with an
N-terminal FLAG tagwasmade by inserting the following oligonucleotide
in the Asp718 sequence preceding the ATG in pAc-sens: FLAG top, GTA
CCAAAATGGACTACAAGGACGACGATGACAAGC; FLAG bottom,
GTACGCTTGTCATCGTCGTCCTTGTAGTCCATTTTG.
The SENS coding sequence was cloned in the mammalian expression
vector pEGFP-C1 (Clontech) for transfection in HeLa cells and expres-
sion of a GFP-SENS fusion protein. The following primers were used to
amplify the sens sequence by PCR using pAc-sens as the template. The
restriction sites for SalI and XmaI used in cloning are underlined, and the
ATG start codon and TGA stop (TCA on reverse strand) are in bold: Sens
forward, ACGCGTCGACATGAATCACCTATCGCCG; Sens reverse, TA
AACCCGGGTCAGCAGCTGCTGCTGCTCAC.
Site-directed mutagenesis of lysine to arginine for the predicted
SUMOylationmotifs in SENS p-EGFP-C1-sens (see Table 2) was carried out
using theQuikChangemutagenesis kit fromAgilent Technologies and the
primers below, except for K533R, which was PCR amplified as a linear
fragment with the mutation in the 3= primer. Primers (with the codon
encoding arginine indicated in boldface) included (i) K229R forward,
TACGGCCTGAGGATGGAGGAG, and reverse, CTCCTCCATCCTCA
GGCCGTA; (ii) K249R forward, GTGCGAAAGTTCAGGTATGAGCGC
AGAACTGC, and reverse, GCAGTTCTGCGCTCATACCTGAACTTTC
GCCAC; (iii) K313R forward, GCACTTGAAGCTGAGGAGCGAGCAG
CCGC, and reverse, GCGGCTGCTCGCTCCTCAGCTTCAAGTGC; (iv)
K327R forward, CATCGCATCAGGGACGAGCAG, and reverse, CTGC
TCGTCCCTGATGCGATG; (v) K533R forward, ACGCGTCGACATG
AATCACCTATCGCCG, and reverse, TAAACCCGGGTCAGCAGCTGC
TGCTGCTCACCTCCATCCTCA; (vi) K476R forward, GTGTGCCTGA
GGGCCTTCAGC, and reverse, GCTGAAGGCCCTCAGGCACAC; (vii)
K453R forward, TTCCACCAAAGGTCGGACATG, and reverse, CATGT
CCGACCTTTGGTGGAA; (viii) K91R forward, ATGACCCCCAGATCG
CCCGCC, and reverse, GGCGGGCGATCTGGGGGTCAT; (ix) K509R
forward, TTCCAGCGCAGGGTGGATCTG, and reverse, CAGATCCAC
CCTGCGCTGGAA; (x) K448R forward, TATTGTGGCAGGCGGTT
CCAC, and reverse, GTGGAACCGCCTGCCACAATA; (xi) K420R
forward, CAGTGTGGCAGGAGCTTCAAG, and reverse, CTTGAAGCT
CCTGCCACACTG; and (xii) D511A forward, CAGCGCAAGGTGGCT
CTGCGACGTCAT, and reverse, GTCGCGTTCCACCGAGACGCTGC
AGTA.
The RKVD SUMO motif at amino acids 510 to 512 within the SENS
sequence of pAc-FLAG-sens was mutated to give SENSK509R and
FIG 1 SUMO enhances the transcriptional synergy between SENS and pro-
neural proteins in S2 cells. (A, B) Schematic illustration of the binary switch
model for proneural gene transcriptional regulation by SENS (29). (A) In the
ectodermal cells surrounding the SOP, low levels of SENS promote DNA-
binding-dependent repression of proneural gene transcriptional activation by
proneural-DA heterodimers (bHLH). (B) In the SOP, higher levels of SENS
synergize with the proneural proteins to enhance proneural gene transcrip-
tional activation independent of DNA binding by SENS. (C, D, and E) Lucif-
erase assays for ATO (C and E) and SC (D) reporter genes in S2 cells. Note that
the E-box reporter constructs used for these three panels lack SENS binding
sites. (C and D) Cotransfection of plasmids expressing SUMO and UBC9
(black bars) has a repressive effect on proneural reporter gene transcriptional
activation regardless of the presence of proneural proteins (bars 1 to 4). How-
ever, SUMO/UBC9 enhances transcriptional activation driven by proneural-
SENS complexes (column 6 compared with column 5). (E) The ULP1 SUMO
protease (black bars) promotes a dose-dependent decrease in transcriptional
synergy of the ternary ATO/DA/SENS complex (bars 6 to 9 compared with bar
5). In the absence of SENS, ULP1 has no effect on transcriptional activation
(bars 2 and 4 versus 1 and 3, respectively).
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SENSD511A variants for use in the S2 cell luciferase assay using the
QuikChange II XL mutagenesis kit from Agilent Technologies and the
following primers: for SENSK509R, SensA1744G forward, GTCCTTCCAG
CGCAGGGTGGATCTGCG, and SensA1744G reverse, CGCAGATCCA
CCCTGCGCTGGAAGGAC; for SENSD511A, Sens A1750C forward, CCA
GCGCAAGGTGGCTCTGCGACGTCATC, and SensA1750C reverse,
GATGACGTCGCAGAGCCACCTTGCGCTGG.
For Western blot analysis, a construct for expression of SENS with a
3 FLAG N-terminal tag (Sigma), under the control of the Actin5C pro-
moter, was made by Gateway cloning (Invitrogen) of the SENS coding
sequence into the vector pAFW. pAFW was a kind gift from Terence
Murphy, Carnegie Institution of Washington.
pUASTattB vector for germ line transformation (see below) using the
phiC31 integrase was a kind gift from J. Bischof (10). For pUASTattB
constructs the coding sequences for wild-type SENS, SENSK509R, and
SENSD511A were amplified from the relevant pAc-FLAG-sens constructs
by PCRusing the following primers (with restriction sites in bold) and the
Roche Expand Long Template PCR system: SensNotI forward, GACGCG
GCCGCAAAATGAATCACCTATCGCCGCCGCC; SensXbaI reverse,
GACTCTAGAGGATCAGAGATTGCCGCCTAGCCTCG.
The PCR products were TA cloned using the Strataclone PCR cloning
kit (Agilent Technologies), their sequences were checked using the se-
quencing primers described below, and then they were cloned in
pUASTattB using the NotI and XbaI restriction sites. The sequencing
primers used were pUASTattB forward, CAACTGCAACTACTGAAATC
TGCC, and reverse, CACACCACAGAAGTAAGGTTCC.
S2 cell cotransfection luciferase assays. S2 cell cotransfection assays
were carried out using thePromegaDLR systemas describedpreviously (49).
Each cotransfection was done in triplicate, and the data in each experiment
were normalized to a zero expression construct data set (i.e., cells transfected
with empty vector). Concatemerized E-box luciferase reporter constructs
wereasdescribed inreference49.ForpGL4-AcPthe455-bpachaetepromoter
fragmentmade by PCR from genomicDNAusing the following primers was
cloned in pGL4-luc usingAsp718 andHindIII: Ac forward, GATCGGTACC
GGATGGCCACTTTCAATAGGAG, and Ac reverse, GCGCAAGCTTCG
CTGCCCAAAGCCATTTTAAG.
SUMO system expression constructs, kindly donated by A. Courey,
included pPAC-HA-Ubc9, pPAC-HA-Smt3, pPac-HA-DmSAE1, and
pPac-HA-Dm-SAE2 (9) and pPAC-FLAG-Ulp1 (8, 57). Cells were incu-
bated for 24 h at 27°C posttransfection and pelleted, and lysates were
made using the Promega passive lysis buffer. For low proneural concen-
tration for luciferase assays, 0.5 ng proneural expressing plasmids was
transfected per 1ml of cells at 0.5 106 cells/ml, while for high proneural
concentration the amount of expression construct was 20 ng. SENS ex-
pression plasmid was always at 20 ng per ml of cells. For Western blot
analysis, expression plasmid per ml of cells was for SENS at 50 ng, for
SUMO at 12.5 to 50 ng, for ULP1 at 50 to 100 ng, and for UBC9 at 50 ng.
Western blot lysates were processed in the presence or absence of 20 mM
N-ethylmaleimide (NEM) (Sigma-Aldrich) as indicated. Lysate (40%; 20
l from 50 l lysate per 1 ml of cells) was loaded in each case onto an 8%
SDS-PAGE gel, followed by Western blotting. Protein was visualized us-
ing monoclonal mouse anti-FLAG antibody (Sigma).
HeLa cell cotransfection localization assay. HeLa cells were main-
tained and transfected as described previously (12). Constructs used for
transfection were RFP-SUMO-1 and RFP-SUMO-2 (12) and wild-type
and mutated pEGFP-C1-SENS as described above. The cells were incu-
bated for 12 h at 37°C before analysis by fluorescence microscopy.
Germ line transformation. Transgenic Drosophila lines were made
using the phiC31 integrase system to insert SENS plasmids into an attP2
landing site on chromosome 3L (10, 23). Insertion at the same landing site
allowed quantitative comparison of their effects on neurogenesis.
pUAST-SENS-attB wild-type and mutant constructs were injected into
embryos heterozygous for the attP2 landing site (23) and for the phiC31
integrase driven by the nanos promoter, located on the X chromosome
(Genetic Services Inc., Sudbury, MA). Male flies that developed from
injected embryos were crossed to w1118 virgin females, and transformants
were selected from the offspring based on the presence of the red eye color
due to expression of the vector-borne w gene. Red-eyed males were se-
lected (ensuring loss of the integrase) and crossed to yw; Ly/TM3, Sb.
Transgenic stocks were made by selecting red-eyed Sb males and females
and crossing them together to allow selection of non-Sbhomozygous flies.
Yeast two-hybrid analysis. Yeast two-hybrid analysis employed the
Matchmaker Two-Hybrid system (Clontech). PCR was used to amplify
the coding sequences of SUMOACT (an activated form of Drosophila
SUMO lacking the 4 C-terminal residues, revealing the C-terminal digly-
cine) and SUMOGG (nonconjugatable SUMO) from pPAC-smt3 (9)
for cloning in the yeast two-hybrid pAS2-1 bait vector, using the SfiI and
XmaI sites to make a construct encoding a fusion of the relevant SUMO
variant with the yeast GAL4 DNA binding domain (BD). The primers
usedwere as follows: pAS2-1-Smt3 forward primer (the SfiI site is in italics
and the ATG start methionine in bold; used for both dSmt3-GG and
dSmt3-GG), TATAGGCCATGGAGGCCATGTCTGACGAAAAGAAG;
pAS2-1-Smt3-GG reverse primer (XmaI site in italics), ATATCCCGGGT
TAGCCACCAGTCTGCTGCTG; pAS2-1-Smt3-GG reverse primer
(XmaI site in italics), ATATCCCGGGTTAAGTCTGCTGCTGGTAAAC.
SENSwild-type, SENSK509R, and SENSD511A sequences were cloned in
the SfiI/XmaI sites of the prey plasmid pACT2 following PCR from the
appropriate pEGFP-SENS variant construct using the following primers
tomake constructs encoding fusions of the yeast GAL4 activation domain
with the relevant SENS variant: pACT2 SENS forward primer (the SfiI site
is shown in italics and ATG in bold), TATAGGCCATGGAGGCCATGAA
TCACCTATCGCCG; and pACT2 SENS reverse primer (the XmaI site is
shown in italics and STOP [TCA] in bold), ATATCCCGGGTCAGCAGC
TGCTGCTGCTCAC.
Transformations of the CG1945 strain and plating on selective plates
were performed according to the manufacturer’s protocol. 5-Fluoro-
orotic acid was from Stratech Scientific. Amino acids and 3-aminothy-
mine were from Sigma, yeast extract-peptone-dextrose (YPD) medium
was from Clontech, and Difco yeast nitrogen base, Bacto peptone, and
Bacto yeast extract were from Becton Dickinson.
In vitro SUMO conjugation assays. In vitro SUMO conjugation as-
says were carried out according to the method described in reference 12
for N-terminally glutathione S-transferase (GST)-tagged 20-amino-acid
SENS fragments (GST-SENS-f) corresponding to amino acids 500 to 519
of the full-length SENS for wild-type, K509R, and D511A SENS variants.
The reaction mixture contained 0.5 g GST, 2 g GST-SENS-f, 0.5 g
GST-D4* (a DAXX-4 fragment, which served as a positive control), 2 g
His-SUMO, 0.1 g recombinant GST-SAE1/2 (E1), 0.1 g GST-Ubc9
(E2), and 10l ATP regenerating system (50mMTris-HCl, pH 7.5, 5mM
MgCl2, 2 mM ATP, 10 mM creatine phosphate, 3.5 U/ml creatine kinase,
and 0.6 U/ml inorganic pyrophosphatase). After incubation at 37°C for 3
h, the mixture was stopped by adding sample buffer, boiled, and then
separated by 12.5% SDS-PAGE, and SUMOylation substrates and conju-
gates were visualized by blotting with rabbit anti-GST antibodies. The
SUMOylation conjugates were confirmed by blotting the stripped mem-
branes with rabbit anti-His antibodies.
RESULTS
SUMO promotes transcriptional activation by the proneural/
SENS ternary complex in S2 cells. The E-box-dependent tran-
scriptional activation synergy between proneural proteins and
SENS can be observed in an S2 cell luciferase reporter gene assay
using both a construct based on an autoregulatory enhancer from
the ac gene (acP-luc) (3, 29) and concatemerized E-box reporter
constructs (sc-luc and ato-luc) (49) (Fig. 1). At low plasmid levels,
transfection of either ATO/DA or SC/DA does not result in signif-
icant activation of the concatemerized E-box luciferase reporter
constructs (Fig. 1C and D, column 3). SENS transfected alone has
no effect on transcriptional activation, even at high concentra-
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tions (49). However, cotransfection of SENS and proneural/DA
results in significant activation (49) (Fig. 1C and D; compare bars
5 and 3 in each panel). This effect is thought to occur via the
formation of a ternary proneural/SENS complex. It is E-box de-
pendent but does not require theDNA-binding ability of SENS (3,
29, 49) (Fig. 1). It has previously been shown that Drosophila
SUMO substrates can be SUMO modified in S2 cells both by en-
dogenous SUMO and by SUMO expressed from a cotransfected
expression construct (9). We therefore used this assay to test the
effect of SUMO components on proneural/SENS activity.
When constructs expressing components of the SUMOylation
pathway (UBC9 [the SUMO conjugating enzyme] and Smt3
[SUMO]) are transfected into S2 cells, there is a strong downregu-
lation of background reporter gene activity (Fig. 1C andD; see bar
2 in each panel), which is perhaps consistent with SUMO’s general
role in repression of transcription; for example, by histone
deacetylase (HDAC) recruitment (18). This general repressive ef-
fect of SUMOylation is still evident in the presence of SC/DA or
ATO/DA (Fig. 1C andD; bar 4 compared to bar 3 in each case). In
contrast, however, SUMO promotes a dramatic increase in SC/
DA/SENS and ATO/DA/SENS activation of reporter genes (Fig.
1C and D, bar 6 versus bar 5). This observation is consistent with
a role for SUMOylation in specifically promoting the formation,
function, or stability of the proneural/SENS complex.
SUMO modification is a transient process, and the SUMO
moiety can be removed from a modified protein by SUMO pro-
teases. In common with yeast and mammals, the Ulp1 cysteine
protease performs de-SUMOylation in Drosophila (8, 57). In the
reporter gene assay, cotransfection with increasing amounts of
Ulp1-expressing plasmid caused a corresponding decrease in
ATO/DA/SENS-dependent reporter gene activation for ato-luc
(Fig. 1E), sc-luc, and acP-luc (data not shown). This occurred in
the absence of cotransfected SUMO/UBC9, consistent with an
effect via endogenous SUMO pathway components within the S2
cells. We conclude that proneural/SENS activity is enhanced by
SUMOylation, and indeed it is largely dependent on endogenous
SUMOactivity in S2 cells. Furthermore, the effect of SUMOylation is
seen only in the presence of SENS, consistent with SENS being the
target of SUMOylation.
SENS interactswith SUMOin a yeast two-hybrid assay and is
SUMOylated in S2 cells. The effect of SUMO in the S2 reporter
assay suggests an effect via SENS itself. For other SUMO sub-
strates, such as the chromosomal passenger complex protein,
Borealin, and the Daxx transcriptional repressor, interaction with
SUMO has been demonstrated by a yeast two-hybrid assay (12,
36), so we used the same approach to test whether SENS and
SUMO interact. First, we tested the interaction of SENS with the
activated form of SUMO (SUMOACT), which lacks the two C-ter-
minal amino acids of full-length SUMO revealing the C-terminal
diglycine (12). Our yeast two-hybrid results indicated a clear in-
teraction between SENS and SUMOACT, supporting the possibil-
ity that SENS is a substrate for SUMOylation.
We next used the yeast two-hybrid assay to determine whether
SENS also interacts with a nonconjugatable form of SUMO
(SUMOGG) that lacks 6 C-terminal amino acids including the
C-terminal diglycine (37). An interaction was indeed observed
between SENS and SUMOGG (Table 1), suggesting noncovalent
interaction between the two, but this was weaker than that ob-
served with SUMOACT. One possible reason for the weaker inter-
action with SUMOGG is that, in contrast to SUMOACT, the non-
conjugatable form has a mostly cytoplasmic rather than nuclear
location (12). In addition to covalent modification, many SUMO
substrates also interact noncovalently with SUMO via hydropho-
bic regions, and such interactions have been found to be impor-
tant for subsequent covalent modification (44, 58). The interac-
tion of SENS with both SUMOACT and SUMOGG therefore
implies that SENS is a strong candidate for SUMOmodification.
In order to investigate whether SENS is covalently modified by
SUMO, we transfected Drosophila S2 cells with a FLAG-tagged
SENS expression construct and various combinations of plasmids
expressing components of the SUMOylation machinery. Western
blotting with an anti-FLAG antibody was then used to analyze the
lysates (Fig. 2A and B). FLAG-SENSwas detected as a strong band
migrating at 100 kDa (Fig. 2A, arrow). An additional higher-mo-
lecular-weight band (Fig. 2A, asterisk) was observed. This band
was strongly dependent on the presence of the SUMO protease
inhibitor, N-ethylmaleimide (NEM) (Fig. 2B). Moreover, it dis-
appeared upon cotransfection with the SUMO protease ULP1
(Fig. 2A, lane 5). Hence, we conclude that the extra band repre-
sents SUMOylated SENS protein. Interestingly, the additional
band could be observed both in the presence of exogenous SUMO
and/or Ubc9 and with SENS alone, consistent with the conclu-
sion above stating that SENS activity is modified by endoge-
nous SUMOylation activity. Additional higher-molecular-
weight bands may correspond to minor species with more than
one lysine SUMOylated (14).
In HeLa cells SENS localizes to PML bodies in a SUMO-de-
pendent manner. To look for further evidence of an interaction
betweenSENSandSUMO,weanalyzed their subcellular distribution
in cultured cells. Inmammalian cells, SUMO is localized to punctate
subnuclear structures called promyelocytic leukemia protein (PML)
nuclear bodies. Interactionbetween transcription factors and SUMO
can alter their localization to these PML bodies (11, 12, 38, 44). For
example, SUMO-1 modification of the zinc finger protein ZNF198
has been shown to localize it to the PML nuclear bodies of Hek 293
cells (38). Less-distinct punctate staining is also found inDrosophila
nuclei, but its relationship with PML bodies is not clear (41, 57).
Hence,weused localization inHeLacells to investigatewhetherSENS
and SUMO are capable of interacting.
We used GFP-tagged SENS and human RFP-SUMO-1 and
RFP-SUMO-2 to test whether SENS and SUMO colocalize in
HeLa cells (Fig. 3). Human SUMO-1 and SUMO-2 show 52% and
71% identity, respectively, toDrosophila SUMO (52). SUMO-1 or
SUMO-2 localized to the PML bodies of the cell, as shown by
costaining with PML antibody (results not shown) (68). When
GFP-SENS was transfected alone, it localized to the nucleus in a
TABLE 1 Yeast two-hybrid results demonstrating interactions between
SENS and SUMOa
Protein BD-vector BD-SUMOACT BD-SUMOGG
AD-DAXXb ND  ND
AD-SENS   
AD-SENSK509R   
AD-SENSD511A   
a The interactions were confirmed by the presence of colonies on SC-Leu-Trp-His
selective plates (HIS reporter gene) and also by positive -galactosidase assays. AD and
BD, GAL4 activation and DNA-binding domains, respectively, in the yeast two-hybrid
prey and bait constructs; ND, not done.
b Positive control.
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diffuse pattern excluding the nucleoli (Fig. 3A).When GFP-SENS
and RFP-SUMO-1 or 2 were cotransfected, the SENS protein be-
came dramatically redistributed so that it colocalized with the
SUMO in the PML bodies (Fig. 3B and C). This is consistent with
a direct interaction between SENS and SUMO in HeLa cells.
Lysine at position 509 is important for SUMO-dependent
SENS relocalization in HeLa cells. As the HeLa cell results are
consistent with a direct interaction between SUMO and SENS, we
investigated the effects of mutating potential SUMO target lysines
on the localization of SENS. Typically SUMO is conjugated to
lysine residues in the consensus sequenceKxD/E (where is a
large hydrophobic residue and x is any residue) (51), although
not all such motifs will be SUMOylated and nonconsensus
SUMOylation sites are also known (27). Analysis of the SENS
sequence using SUMOplot (Abgent) identified 11 potential sites
for SUMO modification, five of which are predicted with high
probability (Fig. 3D). We investigated the importance of these
motifs in the HeLa cell localization assay. Lysines in the predicted
SUMO target sequences were mutated to arginine to prevent
SUMO conjugation, either individually or in combination (Table
2), and the subnuclear localization in HeLa cells was determined
for each of thesemutants. This showed that up to 8 of the 11motifs
could be mutated in combination (SENS-m8 construct; Fig. 4B)
with no disruption of the localization of the SENS protein and no
change in its relocalization with SUMO upon cotransfection (Fig.
4A and C). In contrast, mutation of one additional lysine (K509)
resulted in disruption of the subnuclear localization (construct
SENS-m9; Fig. 4E). Sens-m9 transfected alone was seen in nuclear
dots, distinct from the PML bodies (Fig. 4D), rather than in the
diffuse pattern seen for wild-type protein. Moreover, SENS-m9
did not relocate to PML bodies upon SUMO cotransfection (Fig.
4F). We then examined the effect ofmutating K509 alone.Mutation
FIG 2 SENS is SUMOylated in S2 cells. (A and B) Western blots with anti-FLAG antibody of S2 cell lysates after transfection with plasmids for FLAG-SENS,
SUMO, ULP1, or UBC9 as indicated. (A) Anti-FLAG antibody detects unmodified FLAG-SENS (arrow) and an additional lower-mobility band proposed to be
SUMOylated SENS (asterisk). This SUMO-SENS band is observed when SENS is transfected alone (lane 1) or is cotransfected with plasmids expressing SUMO
(lane 2), UBC9 (lane 3), or both SUMO and UBC9 (lane 4), but it is absent when the SUMO protease Ulp1 is cotransfected (lane 5). The presence of the
SUMO-SENS band in the absence of cotransfected SUMO (lane 1) suggests SENSmodification by endogenous SUMO. (B) The SUMO-SENS band is dependent
on the presence of the SUMOprotease inhibitor, NEM, in the lysates (lane 2 compared to lane 1). Note that NEM is present in all lysates in panel A. (C)Western
blot with anti-FLAG antibody of S2 cell lysates after transfection with plasmids for FLAG-SENSD511A, SUMO, ULP1, or UBC9 as indicated. SUMOylated SENS
(asterisk) was detected as for the wild-type protein.
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of K509 (the SENSK509R mutant construct) resulted in alteration of
the subnuclear localization of SENS in a proportion (59.3% 2.7%)
of the transfected cells (Fig. 4G and H). In addition, SENSK509R
failed to colocalize with SUMO in most cells (Fig. 4I and J; no
colocalization in 95.3% of cells). We conclude that K509 is
important for SUMO-dependent localization of SENS and may
be a major site of SUMOylation, although other sites may con-
tribute as well.
As lysine residues can be subject to various posttranslational
modifications, including acetylation and ubiquitination, we con-
firmed a SUMO-specific effect of K509 by mutating the third res-
idue in the SUMOylation motif to give SENSD511A. The third res-
idue is specific for UBC9 interactions and would not affect other
modifications of the lysine residue in the motif (45). SENSD511A
failed to colocalize with SUMO in all cells (data not shown), con-
sistent with mutation of the motif disrupting a covalent interac-
tion with SUMO.
In contrast with the colocalization assay results, both
SENSD511A and SENSK509R retained the ability to interact with
SUMO in the yeast two-hybrid assay (Table 1) consistent with the
presence of additional SUMO target lysines. For both SENSD511A
and SENSK509R, interaction with SUMOACT was, however, weaker
than for wild-type SENS, consistent with an important role for
this SENS SUMOylation motif in the SUMO-SENS interaction.
SENS SUMOylation mutants are refractory to SUMOmodi-
fication in vitro but not in S2 cells, suggesting SUMOylation at
an alternative site or sites in S2 cells. In order to test the ability of
the putative SUMO acceptor K509 to be SUMOylated, we used an
in vitro SUMOylation assay (12, 60). GST-tagged 20-amino-acid
peptides containing the K509 SUMO motif and surrounding
amino acids were used to assess the efficiency of SUMOylation of
wild-type, K509R, and D511A versions of the motif. In this assay
only the wild-type sequence was SUMOmodified, demonstrating
that K509 is indeed an acceptor for SUMOylation and that both
mutations prevent this SUMOylation (Fig. 5A and B).
We then tested the effects of the mutations in the context of
full-length SENS in S2 lysates. In this case SUMO-modified SENS
was still seen for both SENSD511A (Fig. 2C) and SENSK509R (data
not shown).We suggest that thismay arise due to SUMOylation at
one or more alternative lysines in the SENS sequence, as has been
FIG 3 SENS is relocalized to PML bodies in HeLa cells in a SUMO-dependent manner. (A) GFP-SENS transfected into HeLa cells localized diffusely to the
nucleus as indicated by costaining with DAPI (4=,6-diamidino-2-phenylindole) (A	). (B and C) GFP-SENS cotransfected with human SUMO-1 (B to B	) or
SUMO-2 (C to C	) redistributed in a punctate pattern showing colocalization with SUMO-1 or SUMO-2. (D) Schematic diagram of SENS (541 amino acids in
length) showing the four C-terminal Zn fingers (yellow) and the 11 SUMOylation motifs predicted by SUMOplot (Abgent). Higher-probability sites are shown
in red and lower-probability sites in blue.
TABLE 2 Summary of the SENS SUMO motif mutations
Mutant name Lysine(s) mutated
Sens wild type None
Sens-327-mut K327
Sens-229-mut K229
Sens-533-mut K533
Sens-313-mut K313
Sens-249-mut K249
Sens-M2 K327, K533
Sens-M3 K327, 313, 533
Sens-M4 K327, 313, 533, 249
Sens-M5 K327, 313, 533, 249, 229
Sens-M6 K327, 313, 533, 249, 229, 476
Sens-M7 K327, 313, 533, 249, 229, 476, 453
Sens-M8 K327, 313, 533, 249, 229, 476, 453, 91
Sens-M9 K327, 313, 533, 249, 229, 476, 453, 91, 509
Sens-M10 K327, 313, 533, 249, 229, 476, 453, 91, 509, 448
Sens-M11 K327, 313, 533, 249, 229, 476, 453, 91, 509, 448, 420
Sens-509-mut K509
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seen for other SUMO substrates subject to SUMOylation at un-
identified sites (14, 54). The presence of alternative SUMOylation
sites is also supported by the yeast two-hybrid interaction data.
However, the strong effect of K509 motif mutations on SENS co-
localizationwith SUMO inHeLa cells suggests that this sitemay be
of major importance in vivo.
SENS SUMOylationmutants are refractory to SUMO stimu-
lation of proneural/SENS transcriptional activation. We tested
FIG 4 Mutation of SUMOylation motifs in SENS reveals K509 is important for SUMO-dependent SENS relocalization in HeLa cells. (A to C) Mutation of 8 of
the 11 SUMOylation motifs in SENS (SENS-m8 in schematic [B]) had no effect on its localization. (A) SENS-m8 showed a diffuse nuclear distribution similar
to that of wild-type SENS (Fig. 3) (C) In the presence of SUMO-1, SENS-m8 relocalized to the PML bodies in a fashion similar to that of wild-type SENS. (D to
F) Mutation of one extra lysine (K509R) in SENS-m9 (schematic [E]) affected SUMO-dependent relocalization. (D) SENS-m9 showed punctate nuclear
distribution, which does not appear to correspond to the PML bodies. (F) In the presence of SUMO-1 the SENS-m9 protein remained in a wider distribution
pattern thanwas seen for SUMO-1. (G andH) The single-sitemutant SENSK509R showed two different patterns of distribution in the absence of SUMO. The first
pattern (G) was indistinguishable from that of the wild type (compare with Fig. 3A; found in 40.8% 2.7% of transfected cells), while the second (H) showed
the SENSK509R localized in dots, unlike the pattern seen for the wild type but more diffuse than for SENS-m9 (59.3% 2.7% of transfected cells). (I and J) Upon
cotransfection with SUMO-1, relocalization of SENSK509R occurred in a small proportion of cells (data not shown; 4.7%  1.2% of cells), but in most cells
localization was defective, i.e., diffuse with nuclear dots, 53.97% 1.73% of transfected cells (I); and diffuse localization, 41.3% 0.7% of transfected cells (J).
In each case the letter alone shows the GFP-SENS variant (green); a letter followed by one prime shows the RFP-SUMO-1 (red), a letter followed by a double
prime shows red/green overlay; and a letter followed by a triple prime labels the red/green/blue overlay (blue, DAPI [4=,6-diamidino-2-phenylindole]), except in
those cases where SENS variants are transfected alone, and then the triple prime indicates DAPI alone.
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the effect of the K509R and D511A SUMO motif mutations on
proneural/SENS activity in the S2 cell reporter gene assay (Fig. 6).
In contrast to wild-type SENS, the activities of both mutated ver-
sions were unresponsive to UBC9/SUMO cotransfection (Fig. 6B,
bars 8 and 10 compared to bar 6). These data are consistent with
K509 being an important SUMOylation site. Furthermore, they
suggest that SUMOmodification of SENS at K509 promotes pro-
neural/SENS synergy. Our next step was to assess whether
SUMOylation of SENS is important in vivo.
Overexpression of SUMO enhances proneural/SENS-in-
duced neurogenesis in vivo. In Drosophila, ectopic expression of
proneural proteins or SENS induces the formation of supernu-
merary sensory organs (31, 47). To assess whether SUMOylation
of SENS plays a role in vivo, we targeted the expression of SENS
and SC in the wing imaginal discs, using an SOP/PNC GAL4
driver [109(2)68Gal4]. Misexpression of SENS in wing imagi-
nal discs using 109(68)Gal4 results in ectopic external sense
organ (bristle) production due to the specification of supernu-
merary SOPs (Fig. 7A). Misexpression of SUMO using the
same Gal4 driver did not affect bristle number (Fig. 7A). How-
ever, SUMO misexpression was able to enhance the bristle
number increase due to SENS misexpression (Fig. 7A). Inter-
estingly, SUMO misexpression also enhanced the ability of
proneural proteins to promote ectopic sense organs. SUMO
enhanced the production of ectopic bristles in response to SC
misexpression (Fig. 7B).We suggest that the effect of SUMO on
SC function occurs via modification of endogenous SENS. Sig-
nificantly, SUMO also enhances the effect of ATO misexpres-
sion (Fig. 7C). ATO misexpression results in a reduction in
bristle number due to respecification of the SOPs to give inter-
nal chordotonal sense organs (31). Simultaneous misexpres-
sion of SUMO enhanced this reduction by ATO. This suggests
that SUMO does not promote bristle formation per se but in-
stead promotes neurogenesis via a specific effect on proneural/
SENS activity. It is notable that SUMO overexpression alone
has no effect on endogenous neurogenesis, suggesting that
FIG 5 (A, B) In vitro SUMO conjugation assays demonstrate the importance of K509 and D511 residues for SUMOylation. In vitro SUMO conjugation assays
were carried out according to the method described in reference 12 for N-terminally GST-tagged 20-amino-acid SENS fragments (GST-SENS-f) corresponding
to amino acids 500 to 519 of the full-length SENS, for the wild-type K509R and D511A SENS variants, with GST-D4* (DAXX-4 fragment) as a positive control.
The reactions were run on 12.5% SDS-PAGE and then subjected toWestern blotting. (A) SUMOylation substrates (arrowheads) were visualized using anti-GST
antibodies. (B) SUMO conjugates were visualized by probing the stripped membrane from panel A with anti-His antibodies. SUMO conjugates were observed
only for the SENS wild-type fragment (lane 3) and the DAXX-4 fragment (lane 9) and not in lanes 5 and 7 (GST-SENS-f-K509R and GST-SENS-f-D511A,
respectively). A or symbol above each lane indicates the presence or absence, respectively, of His-SUMO.
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SUMO becomes limiting only under the circumstances of pro-
neural/SENS misexpression.
The effect of the SUMOylation motif mutants on SENS’s pro-
motion of ectopic bristles was assessed. Transgenic lines were con-
structed with SENS misexpression constructs inserted into an
attP2 landing site on chromosome 3L (10). Insertion at the same
landing site allowed quantitative comparison of their effects on
neurogenesis (Fig. 8A and B). The 109(2)68Gal4 line was used to
drive ectopic expression of SENS or SENS variants (SENSK509R
and SENSD511A) (Fig. 8A). The two mutated SENS proteins pro-
moted significantly lower numbers of ectopic bristles than did
wild-type protein. The effects of the mutations on the in vivo in-
teraction between SUMO and SENS were also assessed (Fig. 8B).
In this experiment we exploited the temperature dependence of
GAL4 protein production (17) to prevent saturation of the bristle
phenotype, by reducing the temperature of the crosses. Under
these conditions, the differences between the SENS variants alone
were not apparent (Fig. 8B, white bars) but the synergistic effect of
SUMO overexpression was still observed (Fig. 8B, black bars).
Under these conditions, the mutant SENS proteins were less sus-
ceptible than wild-type SENS to the synergistic effect of SUMO
overexpression (Fig. 8B, black bars). The ratio of bristle number
for the SENS/SUMOmisexpression combination compared with
that for SENS alone was 1.7 for the wild type and 1.3 for both the
SENSK509R and SENSD511Amutants. These results indicate that the
K509 SUMOylation site in SENS is important for most of the
genetic interaction with SUMO. The residual presence of interac-
tion is consistent with the suggestion of additional alternative
SUMOylation sites within SENS. However, another likely expla-
nation could be the fact that endogenous (therefore wild-type)
SENS contributes to ectopic neurogenesis induced by UAS-SENS.
Overall, the results are consistent with K509 being important for
SUMO enhancement of SENS activity but do not rule out the
possible importance of other lysines as targets too.
DISCUSSION
SUMO enhances SENS’s ability to promote proneural activity in
reporter gene assays and to promote neurogenesis in vivo. Our
data suggest that SUMO modification promotes proneural gene
autoregulation and is also likely to be important in the regulation
of downstream proneural target genes. SUMOylation has a posi-
tive effect and deSUMOylation a negative effect on transcriptional
activation by proneural/DA/SENS ternary complexes in S2 cells.
In contrast, no effect on proneural protein activitywas observed in
the absence of SENS, suggesting that SENS is the target for SUMO.
This is supported by the interactions between SUMOand SENS in
theHeLa cell relocalization and yeast two-hybrid assays, the direct
covalent interaction between SENS and SUMOdetected in S2 cells
FIG 6 SENS SUMOylation motif mutants are refractory to SUMO stimula-
tion. Transcriptional activation of the ac enhancer reporter gene construct
pGL4-AcE-luc by SC/DA heterodimer is slightly elevated by addition of wild-
type SENS (column 5 versus column 3). This SENS/SC/DA interaction is
strongly and specifically elevated upon coexpression of SUMO and UBC9
results (column 6 versus column 5). In contrast, the SUMO motif mutants
SENSK509R and SENSD511A were unresponsive to the addition of SUMO and
UBC9 (columns 8 versus 7 and 10 versus 9).
FIG 7 Overexpression of SUMO enhances proneural-SENS-induced neuro-
genesis in vivo. The SOP/proneural cluster driver, 109(2)68Gal4, was used to
drive expression of neural proteins either alone or in combination with UAS-
SUMOat 25°C (A andB) and 18°C (C), and the scutellar bristles were counted.
(A) Effect of UAS-SUMO on UAS-SENS phenotype. UAS-SENS promoted
ectopic bristles on the scutellum (for the wild type, the number is four, indi-
cated by a dashed line). Overexpression of SUMO alone did not affect the
bristle number, but it enhanced the effect of UAS-SENS. (B) UAS-SUMO
similarly enhanced the ectopic bristle phenotype driven byUAS-SC. (C) Effect
of UAS-SUMO on UAS-ATO phenotype. In contrast to SENS and SC, misex-
pressed ATO results in a decrease in bristle number from the wild-type num-
ber due to respecification of the SOPs to give internal chordotonal sense or-
gans. Simultaneous misexpression of ATO and SUMO enhanced this
reduction. The effect of SUMO in each case was statistically significant as
assessed by the Wilcoxon test. ****, P
 0.0001; **, P
 0.01.
FIG 8 SENS proteins with SUMOylation motif mutations promote fewer
ectopic bristles than the wild type and show reduced genetic interaction with
SUMO in vivo. The 109(2)68GAL4 line was used to drive ectopic expression of
SENS and SENS variants (SENSK509R and SENSD511A) in the absence or pres-
ence of overexpressed SUMO, and scutellar bristles were counted. (A) Misex-
pression of SENS SUMOylation motif mutant proteins resulted in fewer ecto-
pic bristles than were observed for misexpression of wild-type SENS. Crosses
were incubated at 25°C. (B) SENS SUMOylation motif mutant proteins had
reduced susceptibility to the synergistic effect of comisexpressed SUMO pro-
tein (black bars). Crosses were incubated at 21°C in order to reduce GAL4
activity and hence prevent saturation of the ectopic bristle phenotype upon
comisexpression of SUMOand SENS.One-way analysis of variance (ANOVA)
followed by a post hoc Tukey test showed significant differences between wild-
type and mutant protein phenotypes as indicated by the double asterisks (P

0.01).
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and the in vitro SUMOylation assay, and the effect of mutating a
putative SUMOylation motif in SENS Zn finger 4.
The last assay identified a lysine (K509) in the fourth Zn finger
as a candidate for a major SUMOylation site in the SENS se-
quence. Mutation of this lysine to arginine (K509R) resulted in
disruption of SUMO-dependent SENS interaction in the HeLa
cell assay, a SENS protein refractory to SUMO stimulation in the
S2 cell transcriptional assay, and reduced genetic interaction be-
tween SENS and SUMO in vivo. Furthermore, evidence fromyeast
two-hybrid assays and from analysis of S2 lysates for SENSK509R
suggested that additional unidentified lysines may also be
SUMOylated. Interestingly, the basal transcriptional synergy be-
tween SENS and proneural/DA heterodimers observed in S2 cells
appears to be largely dependent on endogenous SUMOylation, as
the synergy is strongly reduced by ULP1 cotransfection. Consis-
tent with this, proteomic analysis has shown that S2 cells express
SUMO, UBC9, and UBA2 (SAE1) proteins (24).
SUMO affects the activity of the proneural/DA/SENS ternary
complex. While our evidence suggests that SENS is the target of
SUMOylation, we do not rule out the possibility that the other
proteins of the complex may also be SUMOylated, but at present
there is no evidence for this. Notably, the ATO sequence has no
KxD/E motifs, while SC has been shown to be unaffected by
SUMOylation in a separate study (1). DA has three potential
SUMOylationmotifs, butmutation of each of these does not affect
proneural/DA/SENS synergy (our unpublished observations).
Our evidence suggests that SUMOylation of SENS enhances
transcriptional synergy via an effect on the proneural/SENS ter-
nary complex itself. Howmight SENS SUMOylation mediate this
increase in transcriptional synergy? SUMOylation can exert a pos-
itive effect on transcriptional activation by various mechanisms
including alteration of subcellular localization and mediation of
interaction with transcriptional coactivators or DNA (40, 61, 64).
In the present case, we suggest that either (i) SUMOylation in-
creases the affinity of SENS for the proneural protein heterodimer,
hence favoring formation of the more transcriptionally active ter-
nary complex; (ii) SUMOylation increases the transcriptional ac-
tivation or DNA-binding ability of the ternary complex, perhaps
by inducing a conformational change; or (iii) SUMO simply sta-
bilizes SENS. SUMO is known tomodulate protein-protein inter-
actions in other systems: for example, SUMOylation of RanGAP1
promotes binding of RanB2 either by creating or exposing a bind-
ing site (46), while nuclear magnetic resonance (NMR) studies
have provided direct evidence of a SUMOylation-induced confor-
mational change in thymine-DNA glycosylase (56). The identified
SUMO site of SENS (K509) is within the fourth Zn finger. This is
significant because the Zn finger has been shown to be unimport-
ant for DNA binding by SENS but contributes to the transcrip-
tional synergy mediated by proneural/SENS interaction (3). It is
conceivable therefore that SUMOylation at this site increases the
affinity of SENS for proneural/Da heterodimers. This would be
similar to the proposed enhanced interaction between the TEA
family transcription factor Scalloped and its coactivator Vestigial
upon SUMOylation of the latter (59).
A major effect of SENS (and therefore SUMO) in promoting
SOP specification appears to be via promoting proneural/DA ac-
tivation of autoregulatory enhancers. This proneural/SENS auto-
regulatory synergy is thought to have an important role in bypass-
ing the negative regulatory effects of the Hairy/E(SPL) (HES)
bHLH repressor proteins downstream of Notch signaling (29). It
is therefore interesting that another role for SUMOylation in SOP
specification has recently been identified in relation to HES re-
pressors. A model has been proposed in which the repressive ac-
tivity of HES proteins during neurogenesis (as well as segmenta-
tion and sex determination) is disrupted by the SUMO-targeted
ubiquitin ligase (STUbL) Degringolade (DGRN) (1, 2, 5). DGRN
binds to SUMOylated Groucho (GRO), the corepressor of HES.
This interaction, as well as ubiquitination of the HES proteins, is
thought to disrupt theHES-GRO interaction, leading to increased
neurogenesis. Hence, these two SUMO-dependent mechanisms
(i.e., increased SENS coactivation and decreased HES repression)
may work in a complementary manner to enhance neurogenesis
(Fig. 9). It will be important to determine how SOP-specific
SUMOylation is regulated in order to elucidate the developmental
mechanisms involved.
As well as acting as a proneural coactivator, SENS directly re-
presses some target genes via binding to S box motifs. It is there-
fore conceivable that SUMO can relieve SENS repression of its
targets by its promotion of ternary proneural-SENS formation,
effectively sequestering SENS from binding to its target S boxes.
For example, SENS directly represses the SOP-specific gene rhom-
boid (rho), the activation of which is crucial for the epidermal
growth factor receptor (EGFR)-dependent recruitment of sec-
ondary SOPs during neurogenesis (25, 39, 65, 69). ATO indirectly
activates rho expression in larval abdominal SOPs by binding
SENS and preventing it from binding and repressing the rho en-
hancer (65). If, for example, SUMOylation enhances SENS bind-
ing to ATO, then it may play a role in activation of rho and other
direct targets of SENS repression.
SENSbelongs to theGPS (Gfi1/Pag-3/SENS) family of proteins
(30), and its mammalian orthologues are the oncogenes Gfi1 and
Gfi1b. The Gfi proteins differ from SENS in containing transcrip-
tional repression SNAG domains near their N termini, and Gfi1
and Gfi1b have been reported to act mainly as transcriptional
repressors (22, 71). Despite these differences, in the mammalian
peripheral nervous system Gfi1 functions in close connection to
proneural factors. For example, it works in concert with Atoh1
(themammalian homologue of ATO) in the specification of inner
FIG 9 A model for the role of SUMO in SOP specification. This model com-
bines our investigation of SENSwith recent studies ofHES-GROUCHO (1, 5).
(A) In the ectodermal cells adjacent to the SOP, SENS acts as a DNA-binding-
dependent repressor of proneural gene autoactivation by proneural-DA het-
erodimers (bHLH) (29). An additional level of proneural gene repression re-
sults from E(SPL)-GROUCHO (HES-GRO) corepressor complexes binding
to both SENS and the bHLH heterodimer (3). (B) In the SOP, SUMOylation
(S) of SENS promotes SENS-proneural transcriptional activation of proneural
gene expression. Also in the SOP, SUMOylation of GRO promotes its binding
by the ubiquitin ligase DGRN, an association that disrupts the association
of GRO and E(SPL), leading to derepression (1, 5). The S-box is the SENS
binding site and the E-box is the proneural-DA heterodimer binding site.
In this panel the S-box is shown unoccupied, but it is not known whether
SUMOylation of SENS prevents its DNA binding.
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ear hair cells (35, 48, 63, 67). Gfi1 also has a crucial role in the
formation of retinal ganglion cells in themammalian eye, working
downstream of a different ATO homologue, Atoh7 (63, 66). Gfi1
also has key developmental roles in the lung and intestine, work-
ing together with the mammalian AC/SC homologue Ascl1 in
pulmonary neuroendocrine cell production (34) and with Atoh1
in the production of secretory cells of the intestine (55).
It has been suggested that Gfi1 and the mammalian proneural
proteinsmay act as transcriptional coactivators in a way similar to
that of the Drosophila proteins (34, 55, 63), although direct evi-
dence for this is lacking. If corroborated, such interactions could
conceivably be modulated by SUMO in a mechanism similar to
that which we have found inDrosophila. Interestingly, this is sup-
ported by the observation that, like SENS, Gfi1 associates with
SUMO pathway proteins including the SUMO-conjugating en-
zyme UBC9 in a yeast two-hybrid assay (16), although no other
evidence has so far been reported for SUMOylation of Gfi1.While
SENS has four C-terminal Zn fingers, Gfi has six. The sixth Zn
finger of Gfi1 is not needed for DNA binding and is equivalent to
the fourth Zn finger of SENS. This is the location of the putative
SUMOylated lysine (K509) in SENS, which is completely con-
served in the context of the SUMOylation motif in Zn finger 6 of
Gfi1. In conclusion, it is possible that Gfi1 activity ismodulated by
SUMOylation, and this could have an effect via amolecularmech-
anism similar to that which we have identified for SENS.
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